Medication info
Lowstar Tablet 40/10 mg

Lowstar Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Telcon RF Pharmaceutical Co., Ltd.
Appearance
The tablet is a biconvex oval-shaped double-layer tablet that is white and light gray.
Packaging
30 tablets/PVP [(10 tablets/PTPX3)]
Approval status
Active

MFDS item code 201904619 · Approved 2019.07.08

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Dose adjustment using the individual components (amlodipine or telmisartan) is recommended before administering this drug; however, if blood pressure is not controlled with an individual component as described below, switching directly to this drug may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults 75 years of age or older, clearance of amlodipine is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
Administration of this drug is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Telcon RF Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This drug effectively lowers blood pressure in patients with essential hypertension who are not sufficiently controlled by monotherapy with either amlodipine or telmisartan, thereby reducing the risk of cardiovascular complications. This treatment aids in blood pressure control through vasodilation or blood pressure control mechanisms. Consequently, proper management of blood pressure contributes to improved heart and vascular health. Therefore, the use of this drug is recommended for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Dose adjustment using the individual components (amlodipine or telmisartan) is recommended before administering this drug; however, if blood pressure is not controlled with an individual component as described below, switching directly to this drug may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults 75 years of age or older, clearance of amlodipine is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

Administration of this drug is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This drug may pose serious risks to the fetus and neonate, particularly during the second and third trimesters of pregnancy, and must be discontinued immediately upon confirmation of pregnancy. This drug is contraindicated in patients with certain conditions. For example, individuals who are allergic to this drug, pregnant or potentially pregnant women, nursing mothers, patients with severe liver or heart problems, and those with severe hypotension should not use it. Careful use under the guidance of a physician is necessary for patients with impaired liver function, gastrointestinal disorders, renal issues, and the elderly. While taking this drug, side effects such as dizziness or peripheral edema may occur, and severe side effects have been reported in rare cases, so immediate consultation with healthcare professionals is necessary if unusual symptoms arise. Pregnant women or those planning to become pregnant are advised to replace this drug with other antihypertensives that have established safety, as using this drug during pregnancy may lead to decreased renal function or skeletal formation abnormalities in the fetus. As this drug lowers blood pressure, hypotensive symptoms may occur, and particularly in patients who are deficient in fluids or salts, pre-existing conditions should be improved or the dosage adjusted under medical supervision. There is a risk of elevated potassium levels in the blood, so patients at risk of hyperkalemia should have their blood potassium levels regularly checked, and caution is needed when taking potassium supplements or drugs containing potassium concurrently. Patients with impaired renal function may experience deterioration of kidney function while taking this drug; therefore, kidney status should be monitored regularly through blood tests. Patients with heart disease should be cautious while taking this drug, as it may increase the risk of angina or myocardial infarction, and they should be attentive to any changes in symptoms. This drug may cause drowsiness or dizziness; thus, caution is advised when driving or operating dangerous machinery. Interactions with other medications may occur, so patients should inform their healthcare providers of any current medications, particularly when taken with lithium, digoxin, warfarin, or non-steroidal anti-inflammatory drugs. In the event of overdose, symptoms such as hypotension, dizziness, and irregular heartbeat may appear, necessitating immediate medical attention. This drug has not been proven safe and effective for children, so its use in this population is not recommended. Store this drug out of reach of children and take it immediately after opening; do not transfer it into another container for safety.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 110 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory disturbance
  • sensory loss
  • taste disturbance
  • tremors
  • extrapyramidal disorder
  • muscle hypertonia
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disease
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • phototoxic reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • frequent urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • interstitial lung disease
  • interstitial pneumonia
  • eosinophilic pneumonia
  • hepatocellular carcinoma
  • cerebral infarction
  • congestive heart failure
  • musculoskeletal pain
  • neck pain
  • nasopharyngitis
  • upper abdominal discomfort
  • upper abdominal pain
  • positional vertigo

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light, so it should be stored in a container that does not allow light to pass through. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C to maintain its efficacy.

Appearance and packaging

Appearance

The tablet is a biconvex oval-shaped double-layer tablet that is white and light gray.

Package unit

30 tablets/PVP [(10 tablets/PTPX3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.